To further evaluate the relative contribution of the myeloid cells to the cancer cell-killing activity in PBMC co-cultures, we depleted the CD14+ monocytes from PBMCs, which retained the CD3+ lymphocytes (Supplementary Fig. 11a). The gene discussed is CD14; the disease is cancer.